Skip to content
All Sections
Subscribe Now
95°F
Tuesday, August 27th 2024
Today's E-Edition
Home Page
Close Menu
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
SUBSCRIBE NOW
Close Menu
Morning Report in your inbox!
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Morning Report in your inbox!
Sign Up
Subscribe
Search
Silicon Valley
95°F
Tuesday, August 27th 2024
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Horizon Therapeutics
(NQ:
HZNP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
116.33 (2)
Ask (Size)
116.37 (25)
Prev. Close
116.30
Today's Range
N/A - N/A
52wk Range
112.10 - 116.27
Shares Outstanding
228,994,568
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Stocks to Buy Low Today With High Hopes for Tomorrow
April 15, 2024
Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns.
Via
InvestorPlace
Rule 17(e) Announcement - Horizon Therapeutics plc
October 06, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Performance
More News
Read More
Peering Into Horizon Therapeutics's Recent Short Interest
October 05, 2023
Via
Benzinga
Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High
October 05, 2023
Via
Investor Brand Network
Rule 17(d) Announcement – Horizon Therapeutics plc
October 05, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today
October 04, 2023
Via
Benzinga
Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High
October 03, 2023
Via
Investor Brand Network
How Is The Market Feeling About Horizon Therapeutics?
September 18, 2023
Via
Benzinga
$1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today
September 12, 2023
Via
Benzinga
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
October 03, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
October 02, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
October 02, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
September 29, 2023
From
Horizon Therapeutics plc
Via
Business Wire
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
September 29, 2023
From
Horizon Therapeutics plc
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
September 27, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics PLC (NASDAQ: HZNP) Sets New 52-Week High in Tuesday Session
September 26, 2023
Via
Investor Brand Network
Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry
September 26, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
September 25, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List
September 19, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
September 13, 2023
From
Horizon Therapeutics plc
Via
Business Wire
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
September 13, 2023
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
September 12, 2023
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
Via
Benzinga
Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement
September 06, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close